ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 1 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $537,000 | -48.4% | 233,459 | -1.4% | 0.01% | -50.0% |
Q2 2021 | $1,040,000 | -42.0% | 236,817 | -4.1% | 0.01% | -47.4% |
Q1 2021 | $1,793,000 | +59.2% | 247,007 | -5.2% | 0.02% | +46.2% |
Q4 2020 | $1,126,000 | +64.6% | 260,678 | +56.6% | 0.01% | +44.4% |
Q3 2020 | $684,000 | -27.5% | 166,410 | +5.8% | 0.01% | -30.8% |
Q2 2020 | $944,000 | +62.5% | 157,358 | +103.8% | 0.01% | +30.0% |
Q1 2020 | $581,000 | -47.6% | 77,205 | -4.2% | 0.01% | -28.6% |
Q4 2019 | $1,108,000 | – | 80,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |